The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 StemCells Inc.  (STEM) Trade Now »     Rate STEM  -  Discuss STEM  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
90.5%
Top:
100.0%
Rate STEM:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

STEM: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

PMD Clinical Trial Graphic_rating_buy STEM
M_154cee056c5e0fda7bacae53d62dc957
N/A

PMD Clinical Trial

<>

In the winter of 2009/10, UCSF Children's Hospital will begin a Phase I safety study sponsored by StemCells, Inc. for a potential new therapy for connatal Pelizaeus-Merzbacher Disease (PMD), which is a rare inherited condition involving the central nervous system. Children with PMD are unable to form myelin. As a result, children have impaired function in language development and memory, and delayed motor skills seen as poor coordination and the inability to walk.

Learn more about Pelizaeus-Merzbacher Disease (PMD)

<> Children found eligi...
By  sam1933   (-6.91%  risk: conservative)  11/19/09 Comment


New Stock Indexes to Track Trends in Healthcare Sector Graphic_rating_buy STEM
Mikerun
73%

Coming Soon. . . a premium service offered in collaboration with Investars YOU for full access to a global database of over 1,000 stocks which are organized and managed within my 20 ProActive HavRx stock indexes . The expected pricing for premium access is $60 per year and will include full access to all of the component stocks in the indexes and tracking data for the indexes. 

<> Emerging Cancer Diagnostic / Therapeutic (Dx / Tx) Index

The actively managed HavRx Emerging Cancer Dx / Tx Index constituents reflect a cross-section of emerging cancer companies with <><><><><><><><><><><><><><><><><><><>< />< /><><>< />< /><><>< />< />< />< /><><>< />< /><><>< />< /><><>< />< /><><><><><><><><><><>< />< /><><>< />< />< />< /><><>< />< /><><>< />< /><><>< />< />< />< /><><>< />< />< />< /><><>< />< />< />< /><><>< />< /><><><><><><><><><>...
By  Mike Havrilla   (+1.04%  risk: conservative)  10/28/09 Comment


Bullish on STEM ... Graphic_rating_buy STEM
M_154cee056c5e0fda7bacae53d62dc957
N/A
Stem cell transplants stalled blindness in rats ...The findings raise hope for use of the treatment in humans with a range of diseases in which the retina become damaged, including age-related macular degeneration or AMD, which affects nearly 30 million people worldwide, including 15 million Americans... http://www.reuters.com/article/companyNews/idUKTRE59I6G120091...
By  sam1933   (-6.91%  risk: conservative)  10/20/09 1 comment


Bullish on STEM ... Graphic_rating_buy STEM
450vampyr_avatar-med
N/A
06/10/09 06/17/09 1 week $1.68 $1.60 -4.79%
By  supratrader   (+16.29%  risk: conservative)  06/17/09 Comment


Stem Cell Index Surges in Past Week Graphic_rating_buy STEM
Mikerun
73%
<> The stem cell trade was back in a big way over the past week, with several stocks in the <font> ETF Innovators Stem Cell Index </font> registering impressive gains, compared to market and biotech ETF benchmarks such as the S&P 500 SPDR (NYSE:SPY) +6%, iShares Nasdaq Biotech (NASDAQ:IBB) +2%, SPDR S&P Biotech (NYSE:XBI +4%). Hot stocks over the past week among the 40 component companies in the stem cell index include NeoStem (AMEX:NBS) +52.2%, Cytori Therapeutics (NASDAQ:CYTX) +37%, and Geron (NASDAQ:GERN) +22%. Two other widely followed stocks from the index registered smaller gains,...
By  Mike Havrilla   (+1.04%  risk: conservative)  05/10/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
WM Washington Mutual Inc
XOM Exxon Mobil Corp
YHOO Yahoo! Inc
AMD Advanced Micro Devices Inc
PG The Procter & Gamble Company
INTC Intel Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on STEM

Visit streetinsider.com


Discussion Wall + Add  

M_154cee056c5e0fda7bacae53d62dc957
sam1933   (-6.91%  risk: conservative)
Meeting with FDA - StemCells, Inc. Provides Update on NCL Program Meeting with FDA StemCells, Inc. (NASDAQ: STEM) today provided an update on the ongoing cli...
+   0 replies

M_154cee056c5e0fda7bacae53d62dc957
sam1933   (-6.91%  risk: conservative)
potential new therapy for connatal Pelizaeus-Merzba.. - PMD Clinical Trial In the winter of 2009/10, UCSF Children's Hospital will begin a Phase I safety study sponsored by StemCells, Inc. for a potential n...
+   0 replies

juiceman   (+0.00%  risk: conservative)
EMGE-Stem Cell Play - I think the significance of this Press Release has been overlooked, and hope the company has more plans to explain its story: Emergent Health Corp. (E...
+   0 replies


More Resources

Graphic_arrow1 About StemCells Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch